Showing results (1581-1590 of 6,509) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|July 20, 2026
Therapeutic targeting of CD47 using a tri-specific NK cell engager to inhibit multiple myelomaRatchaneewan Sumankan, Prin Sungwan, Natthanich Boonsatit, et al.Cancer Immunology, Immunotherapy : CII|June 21, 2026
Smoking-associated modulation of gut microbiota shapes response to immune checkpoint inhibitors in non-small cell lung cancerPo-Yu Chien, Wen-Chien Cheng, Chin-Chuan Hung, et al.Cancer Immunology, Immunotherapy : CII|June 20, 2026
Single-cell and multi-omics integration delineates the landscape of gene-wise intratumor heterogeneity and identifies prognostic biomarkers for immunotherapy in non-small cell lung cancerJianye Yuan, Zelin Weng, Zhenguo Li, et al.Cancer Immunology, Immunotherapy : CII|June 26, 2026
Regulatory B-cell states in NSCLC immunotherapy resistance: mechanisms, spatial context and translational implicationsXin Wang, Xi Li, Jing Zhou, et al.Cancer Immunology, Immunotherapy : CII|July 4, 2026
Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulationYimei Jiang, Haiyan Huang, Haoran Feng, et al.Cancer Immunology, Immunotherapy : CII|July 6, 2026
Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinomaMasamichi Kimura, Koji Nishikawa, Jun Imamura, et al.Cancer Immunology, Immunotherapy : CII|July 3, 2026
Multidimensional analysis of tumour immune microenvironment in HCC: prognostic significance and implications for immunotherapyJun Chen, Mingzhen Zhou, Wenyan Cao, et al.Cancer Immunology, Immunotherapy : CII|July 3, 2026
NKG2A-HLA-E and TIM3-galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancreatic ductal adenocarcinomaYuanyu Lin, Wanhua Feng, Yan Li, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1991
Epidermal growth factor receptor expression in human gliomasS H Torp, E Helseth, A Dalen, et al.Cancer Immunology, Immunotherapy : CII|June 19, 2012
EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cellsAmélie Vézina, Rima Chokor, Borhane AnnabiPageof 651